Spotlight Therapeutics, a startup with a bold vision for delivering CRISPR therapies into the body without the ...
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-two ...
Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro ...
USDA Animal and Plant Health Inspection Service (APHIS) announced on January 23, 2025, that it is reinstating its legacy ...
A new study links a particular gene to the origins of spoken language, proposing that a protein variant found only in humans may have helped us develop speech.
Most mutations that decreased antibiotic susceptibility were related to specific metabolic pathways. A MIC-increase to ...
Citi analyst Yigal Nochomovitz lowered the firm’s price target on Crispr Therapeutics (CRSP) to $82 from $89 and keeps a Buy rating on the ...
The Mahfooza Al-Zayani Humanitarian Award honored the nation’s most inspiring figures in community service, celebrating outstanding contributions to humanitarian work in Bahrain. The prestigious ...
A team of Bahraini specialists has successfully treated a patient with sickle cell disease using the revolutionary CRISPR gene-editing technology, making Bahrain the first country outside the United ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback